AlphaMark Advisors’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$5K 667
2024
Q3
$5K Hold
200
﹤0.01% 571
2024
Q2
$5K Hold
200
﹤0.01% 613
2024
Q1
$5K Hold
200
﹤0.01% 599
2023
Q4
$5K Hold
200
﹤0.01% 589
2023
Q3
$5K Hold
200
﹤0.01% 585
2023
Q2
$5K Hold
200
﹤0.01% 486
2023
Q1
$5K Hold
200
﹤0.01% 496
2022
Q4
$5K Hold
200
﹤0.01% 450
2022
Q3
$5K Hold
200
﹤0.01% 507
2022
Q2
$5K Sell
200
-38,279
-99% -$953K ﹤0.01% 466
2022
Q1
$972K Buy
38,479
+35,454
+1,172% +$915K 0.36% 57
2021
Q4
$80K Hold
3,025
0.03% 202
2021
Q3
$81K Buy
3,025
+925
+44% +$24.9K 0.03% 199
2021
Q2
$57K Hold
2,100
0.02% 220
2021
Q1
$56K Hold
2,100
0.02% 220
2020
Q4
$57K Hold
2,100
0.02% 201
2020
Q3
$57K Hold
2,100
0.02% 196
2020
Q2
$57K Hold
2,100
0.02% 195
2020
Q1
$52K Buy
2,100
+1,900
+950% +$49K 0.03% 177
2019
Q4
$5K Buy
+200
New +$5.17K ﹤0.01% 406

Other funds holding IBDQ

AlphaMark Advisors's IBDQ Position: Q4 2024 in Review

AlphaMark Advisors sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2024, closing a stake of 200 shares — an estimated $5K sold.

AlphaMark Advisors first reported a position in IBDQ in Q4 2019 and held it in 20 quarters. The position peaked at $972K in Q1 2022. 389 funds tracked by Wall St. Rank hold IBDQ as of Q4 2024.

  • AlphaMark Advisors reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 200 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2024, an estimated $5K.
  • AlphaMark Advisors first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2019 and held it in 20 quarters.
  • AlphaMark Advisors's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $972K in Q1 2022.
  • 389 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.